Exciting News! ObvioHealth is thrilled to announce a strategic investment by Guardant Health to accelerate the deployment of oncology clinical trials globally. This partnership is a significant step forward in our mission to revolutionize cancer research and bring innovative treatments to patients faster. Key Highlights: 🌍 Global Reach: With Guardant Health's investment, we aim to expand our oncology trials worldwide, reaching more patients and researchers. 🚀 Enhanced Capabilities: Combining our digital clinical trial solutions with Guardant Health's cutting-edge technology will enhance trial efficiency and data accuracy. 💗 Patient-Centric Approach: Our focus remains on improving patient outcomes and providing seamless trial experiences through our advanced digital platform. "ObvioHealth sees tremendous opportunity in this partnership," said Ivan Jarry, Chief Executive Officer at ObvioHealth. "Guardant's network of researchers enables us to further penetrate the oncology therapeutic area and helps us to expand this important research beyond the 35 countries where we are already conducting trials." Join us on this exciting journey as we work together to transform the landscape of oncology clinical trials. Read the full press release to learn more about this strategic investment: ObvioHealth announces strategic investment by Guardant Health (prnewswire.com) #Oncology #ClinicalTrials #DigitalHealth #CancerResearch #Innovation #ObvioHealth
ObvioHealth
Research Services
New York, NY 39,387 followers
Real-world digital studies that deliver better data.
About us
ObvioHealth is a global digital health organization providing real-world digital clinical trials that deliver better data. Our mobile clinical study application allows for site-less trial design, allowing subjects to use their smartphones to participate in remote monitoring clinical trials from the comfort of their homes. For studies designed to include site visits, our application allows for continuous data collection in between visits to the clinic. By bringing the trial directly to the mobile device of each participant, our study team engages subjects daily using text message and chatbot features. This interaction allows for open communication and helps subjects feel involved during virtual clinical trials. The result: robust data collection, increased compliance, faster recruitment and improved time to completion. To assist with collecting real world data in clinical trials, our app can easy link to various health devices. They include Apple watches, Fitbits and activity trackers, along with Bluetooth scales, blood pressure monitors, and smart health apps. Participants can also use the app to schedule lab visits, or connect it with their PayPal account to receive compensation for decentralized clinical trials. And if the study team needs to talk with the participant during mobile clinical trials, the app allows for easy communication through chat or video. Visit Obviohealth.com to learn more about how our technology can help with observational clinical trials and virtual clinical trials.
- Website
-
https://www.obviohealth.com/
External link for ObvioHealth
- Industry
- Research Services
- Company size
- 51-200 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Digital Recruitment, Participant Registries, Siteless and/or Hybrid Trials, Data Insight, Remote Monitoring Clinical Trials, Virtual Clinical Trials, and Real World Data Clinical Trials
Locations
Employees at ObvioHealth
Updates
-
Patients can become demotivated when #ePRO tasks are too long or complicated. In fact, anything that creates friction in the reporting journey can have a negative impact on engagement. To improve outcomes quality, a more patient-centric approach is required. Learn more: https://lnkd.in/djwM5EtY
-
Don’t settle for digitized versions of poor traditional assessments. ObvioHealth’s #ePRO optimizes #data collection to deliver the #accuracy you need. Learn more: https://lnkd.in/d6CRD_tr
-
When #clinicaltrials are designed to truly #measurewhatmatters, the result is stronger #therapeutic evidence. Learn more about the 5 key #benefits that measuring what matters can bring to your #clinicaltrial: https://lnkd.in/gR6ypXnS
-
For Steve Schaefer, CEO of Mi-Helper, Inc., the idea of conducting a #digital #clinicaltrial was daunting—but only at first. Listen in as he describes how working with ObvioHealth helped him to overcome his hesitations and address his past clinical research pain points. Watch the full testimonial: https://lnkd.in/gzw_Nsv6
-
Choosing the right #device for your #clinicaltrial is part art and part science. These 6 key considerations can help you strike the right balance. Learn more: https://lnkd.in/gexVEsYu
-
Choosing which #digital solutions to implement in a #clinicaltrial can be daunting. So, we’ve created a #playbook to help sponsors and study teams imagine their studies in a #virtual way. You can download it with a click by visiting: https://lnkd.in/gbY8i2jR
-
-
#Diversity in #clinicaltrials is a scientific imperative, a moral and ethical necessity, and a longstanding challenge in clinical research. #DCTs are evolving the industry status quo: https://lnkd.in/gUbG7ym6
-
-
One hour of expert insights, now a five-minute read. Download this summary to access all the highlights and key points from our latest webinar: https://lnkd.in/gi6WQDZv
-
Listen in as members of our team share how remote patient monitoring, featuring real-time dashboards and #AI-enabled alerts, helps them to react earlier to the things that really matter—for safer #clinicaltrials and more accurate #data. For more on how to #measurewhatmatters: https://lnkd.in/dM8KFxay